Caesars Entertainment, Inc. (CZR) Most Active Options
The 19 most actively traded Caesars Entertainment, Inc. (CZR) option contracts at the latest daily snapshot, ranked by volume. Each row shows the contract's price, implied volatility, delta, open interest, and how today's volume compares with its own 30-day average — click a contract to analyze it in the OptiView platform.
Data as of Jul 10, 2026, 8:00 PM ET · OPRA data 15 minutes delayed · For information only — not investment advice.
Most Active CZR Contracts
| Contract | Expiration | DTE | Last | IV | IV rank (30d) | Delta | Open interest | Volume | vs 30d avg |
|---|---|---|---|---|---|---|---|---|---|
| CZR $30 call | Jul 17, 2026 | 7d | $0.46 | 30.0% | 18 | 0.46 | 59,847 | 2,202 | 17.6× avg |
| CZR $31 call | Jul 17, 2026 | 7d | $0.19 | 35.3% | 22 | 0.23 | 37,310 | 460 | 3.7× avg |
| CZR $31 call | Aug 21, 2026 | 42d | $0.36 | 16.5% | 20 | 0.28 | 196 | 155 | 0.5× avg |
| CZR $30 call | Jul 24, 2026 | 14d | $0.50 | 25.3% | 18 | 0.48 | 765 | 98 | 0.1× avg |
| CZR $30 call | Aug 21, 2026 | 42d | $0.80 | 14.0% | 15 | 0.50 | 1,164 | 77 | 0.3× avg |
| CZR $32 call | Jul 17, 2026 | 7d | $0.07 | 44.5% | 12 | 0.14 | 17,865 | 51 | 2.0× avg |
| CZR $30 call | Jul 31, 2026 | 21d | $0.85 | 34.7% | 27 | 0.50 | 760 | 32 | 0.0× avg |
| CZR $15 put | Mar 19, 2027 | 252d | $0.02 | 82.8% | 17 | -0.08 | 113 | 30 | 4.0× avg |
| CZR $32 call | Sep 18, 2026 | 70d | $0.13 | 27.1% | 29 | 0.32 | 6,354 | 27 | 0.4× avg |
| CZR $29.5 put | Jul 17, 2026 | 7d | $0.22 | 19.1% | 9 | -0.32 | 409 | 26 | 1.6× avg |
| CZR $30 put | Jul 24, 2026 | 14d | $0.60 | 27.4% | 25 | -0.52 | 45 | 24 | 9.2× avg |
| CZR $31 call | Jul 24, 2026 | 14d | $0.26 | 50.8% | 39 | 0.37 | 262 | 19 | 0.0× avg |
| CZR $30 call | Aug 7, 2026 | 28d | $0.62 | 46.6% | 40 | 0.52 | 1,393 | 15 | 0.0× avg |
| CZR $29 call | Jul 17, 2026 | 7d | $0.96 | 21.9% | 19 | 0.84 | 13,134 | 15 | 2.2× avg |
| CZR $28 put | Dec 18, 2026 | 161d | $0.17 | 13.4% | 8 | -0.17 | 2,391 | 9 | 2.8× avg |
| CZR $33 call | Dec 18, 2026 | 161d | $0.29 | 13.8% | 28 | 0.19 | 1,383 | 8 | 1.1× avg |
| CZR $33 call | Jan 15, 2027 | 189d | $0.47 | 15.6% | 32 | 0.25 | 1,871 | 8 | 1.1× avg |
| CZR $29 put | Jul 17, 2026 | 7d | $0.03 | 19.4% | 10 | -0.13 | 4,658 | 5 | 0.3× avg |
| CZR $29.5 call | Jul 17, 2026 | 7d | $0.71 | 75.5% | 66 | 0.57 | 128 | 4 | 0.6× avg |
Ranked by volume at the latest daily snapshot. "vs 30d avg" compares today's volume with the contract's own 30-day average.
The most active CZR contract today is the $30 call expiring in 7 days, with 2,202 contracts traded. Calls dominate the most-active list (14 of the top 19), showing where trading interest concentrates. One of these contracts is running well ahead of the usual daily volume.
Explore the payoff profile of option on CZR for free
Build multi-leg CZR strategies, visualize payoffs, and scan the full US options universe with OptiView.
CZR Options FAQ
Which CZR option contract is most active today?
The most traded CZR contract is the $30 call expiring Jul 17, 2026, with 2,202 contracts traded as of Jul 10, 2026.
How does OptiView rank the most active CZR options?
The table lists the 19 CZR contracts with the highest volume at the latest daily snapshot, alongside price, implied volatility, delta, open interest, and each contract's volume versus its own 30-day average.
Methodology. IV rank compares the current 30-day at-the-money implied volatility with its highest and lowest values over the past 52 weeks. Max pain is the strike that minimizes the total payout to option holders at expiration. The call and put walls are the strikes carrying the largest call and put open interest across all expirations. Net gamma exposure (GEX) is measured from the dealer perspective. All statistics are derived from delayed OPRA options data.
Options trading involves significant risk, and losses can exceed your initial investment. Always consult a licensed financial professional before making investment decisions. OptiView does not provide financial advice; all figures on this page are descriptive statistics, not recommendations.